BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28771630)

  • 1. Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD.
    Moreira Soares Oliveira B; Durbeej M; Holmberg J
    PLoS One; 2017; 12(8):e0181950. PubMed ID: 28771630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib partially improves laminin α2 chain-deficient muscular dystrophy.
    Körner Z; Fontes-Oliveira CC; Holmberg J; Carmignac V; Durbeej M
    Am J Pathol; 2014 May; 184(5):1518-28. PubMed ID: 24631023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination.
    Patton BL; Wang B; Tarumi YS; Seburn KL; Burgess RW
    J Cell Sci; 2008 May; 121(Pt 10):1593-604. PubMed ID: 18430779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic laryngeal muscles are spared from degeneration in the dy3K/dy3K mouse model of congenital muscular dystrophy type 1A.
    Häger M; Durbeej M
    Muscle Nerve; 2009 Jan; 39(1):91-4. PubMed ID: 19086066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD.
    Barraza-Flores P; Hermann HJ; Bates CR; Allen TG; Grunert TT; Burkin DJ
    Skelet Muscle; 2020 Jun; 10(1):18. PubMed ID: 32498713
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Christen M; Indzhova V; Guo LT; Jagannathan V; Leeb T; Shelton GD; Brocal J
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiology of the neuromuscular junction of the laminin-2 (merosin) deficient C57 BL/6J dy2J/dy2J dystrophic mouse.
    Edwards JP; Hatton PA; Wareham AC
    Brain Res; 1998 Mar; 788(1-2):262-8. PubMed ID: 9555049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminin alpha2 chain-null mutant mice by targeted disruption of the Lama2 gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy.
    Miyagoe Y; Hanaoka K; Nonaka I; Hayasaka M; Nabeshima Y; Arahata K; Nabeshima Y; Takeda S
    FEBS Lett; 1997 Sep; 415(1):33-9. PubMed ID: 9326364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic plasticity in the dy2J mouse model of laminin alpha2-deficient congenital muscular dystrophy.
    Anderson JL; Head SI; Morley JW
    Brain Res; 2005 Apr; 1042(1):23-8. PubMed ID: 15823249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of dystrophin and β-sarcoglycan significantly exacerbates the phenotype of laminin α2 chain-deficient animals.
    Gawlik KI; Holmberg J; Durbeej M
    Am J Pathol; 2014 Mar; 184(3):740-52. PubMed ID: 24393714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schwann cell myelination occurred without basal lamina formation in laminin alpha2 chain-null mutant (dy3K/dy3K) mice.
    Nakagawa M; Miyagoe-Suzuki Y; Ikezoe K; Miyata Y; Nonaka I; Harii K; Takeda S
    Glia; 2001 Aug; 35(2):101-10. PubMed ID: 11460266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation.
    Vilquin JT; Kinoshita I; Roy B; Goulet M; Engvall E; Tomé F; Fardeau M; Tremblay JP
    J Cell Biol; 1996 Apr; 133(1):185-97. PubMed ID: 8601607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy.
    Moll J; Barzaghi P; Lin S; Bezakova G; Lochmüller H; Engvall E; Müller U; Ruegg MA
    Nature; 2001 Sep; 413(6853):302-7. PubMed ID: 11565031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel mutant transcript of laminin alpha 2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice.
    Sunada Y; Bernier SM; Utani A; Yamada Y; Campbell KP
    Hum Mol Genet; 1995 Jun; 4(6):1055-61. PubMed ID: 7655459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy.
    Girgenrath M; Dominov JA; Kostek CA; Miller JB
    J Clin Invest; 2004 Dec; 114(11):1635-9. PubMed ID: 15578095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merosin and congenital muscular dystrophy.
    Miyagoe-Suzuki Y; Nakagawa M; Takeda S
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):181-91. PubMed ID: 10679965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Muscular dystrophies due to alterations at extracellular space level: congenital muscular dystrophy caused by merosin deficiency].
    Smeyers P
    Rev Neurol; 1999 Jan 16-31; 28(2):141-9. PubMed ID: 10101782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene.
    Xu H; Wu XR; Wewer UM; Engvall E
    Nat Genet; 1994 Nov; 8(3):297-302. PubMed ID: 7874173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy.
    Hall TE; Bryson-Richardson RJ; Berger S; Jacoby AS; Cole NJ; Hollway GE; Berger J; Currie PD
    Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7092-7. PubMed ID: 17438294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructure of muscle spindles in C57BL/6J dy2J/dy2J dystrophic mice.
    James NT; Meek GA
    Experientia; 1979 Jan; 35(1):108-9. PubMed ID: 154410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.